Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
PLEASANTON, Calif., May 11, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will host an analyst day in New York, New York on Thursday, June 22, 2017. The meeting will be held at the Sofitel New York Hotel.
Members of Natus Medical’s management team will host a series of presentations beginning at 9:00 a.m. Eastern Time. A live webcast of the event will be available at http://investor.natus.com and an archive will also be available. Space for the event is limited and pre-registration is required. For additional information on the event, please contact Natus investor relations at [email protected].
About Natus Medical Incorporated
Natus is a leading provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 [email protected]
